Canagliflozin for Japanese patients with chronic heart failure and type II diabetes

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes

Abstract Background Reports that sodium glucose cotransporter 2 inhibitors decrease cardiovascular death and events in patients with diabetes have attracted attention in the cardiology field. We conducted a study of canagliflozin in patients with chronic heart failure and type II diabetes. Methods T...

Full description

Bibliographic Details
Main Authors: Akira Sezai, Hisakuni Sekino, Satoshi Unosawa, Makoto Taoka, Shunji Osaka, Masashi Tanaka
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Cardiovascular Diabetology
Subjects:
SGLT2 inhibitor
Diabetes
Heart failure
Online Access:http://link.springer.com/article/10.1186/s12933-019-0877-2

Internet

http://link.springer.com/article/10.1186/s12933-019-0877-2

Similar Items